Quantitative evaluation of Alzheimer's disease

Progress in Biomedical Optics and Imaging - Proceedings of SPIE

Volumn 7260, Issue , 2009, Pages

  Duchesne, S ^a,b   Frisoni, G B ^c  

^a CENTRE DE RECHERCHE DE L INSTITUT UNIVERSITAIRE EN SANTÉ MENTALE DE QUÉBEC   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

^c IRCCS ISTITUTO CENTRO SAN GIOVANNI DI DIO FATEBENEFRATELLI   (Italy)

Author keywords

Alzheimer's disease; Biomarker; Computational neuroanatomy; MRI; Neuroimaging

Indexed keywords

ALZHEIMER'S DISEASE; COMPUTATIONAL NEUROANATOMY; CONTROL SUBJECT; EIGENSPACE; EVALUATION FACTOR; KOLMOGOROV-SMIRNOV; LINEAR DISCRIMINANTS; MRI; NEUROIMAGING; NEUROPSYCHOLOGICAL; PRINCIPAL COMPONENTS; QUANTITATIVE EVALUATION; REFERENCE DATA; SEPARATING HYPERPLANE; STUDY GROUPS; WEIGHTED DISTANCE;

COMPUTATIONAL COMPLEXITY; DISEASE CONTROL; MEDICAL IMAGING; NORMAL DISTRIBUTION;

COMPUTER AIDED DIAGNOSIS;

EID: 66749100148     PISSN: 16057422     EISSN: None     Source Type: Conference Proceeding    
DOI: 10.1117/12.810804     Document Type: Conference Paper

References (17)

1. Vellas, B., et al., Disease-modifying trials in Alzheimer's disease: a European task force consensus. Lancet Neurol, 2007. 6(1): p. 56-62. (Pubitemid 44880273)
2. Csernansky, J.G., et al., Correlations between antemortem hippocampal volume and postmortem neuropathology in AD subjects. Alzheimer Dis Assoc Disord, 2004. 18(4): p. 190-195 (Pubitemid 40076147)
3. Kloppel, S., et al., Automatic classification of MR scans in Alzheimer's disease. Brain, 2008.
4. Weiner, M., et al., The Use of MRI and PET for Clinical Diagnosis of Dementia and Investigation of Cognitive Impairment: A Consensus Report. 2005, Alzheimer's Association.
5. Chetelat, G. and J.C. Baron, Early diagnosis of Alzheimer's disease: contribution of structural neuroimaging. Neuroimage, 2003. 18(2): p. 525-541 (Pubitemid 36269160)
6. Davatzikos, C., et al., Detection of prodromal Alzheimer's disease via pattern classification of magnetic resonance imaging. Neurobiol Aging, 2008. 29(4): p. 514-523
7. Duchesne, S., et al., MRI-Based Automated Computer Classification of Probable AD Versus Normal Controls. IEEE Trans Med Imaging, 2008. 27(4): p. 509-520
8. Mazziotta, J.C., et al., A probabilistic atlas of the human brain: theory and rationale for its development. The International Consortium for Brain Mapping (ICBM). Neuroimage, 1995. 2(2): p. 89-101.
9. McKhann, G., et al., Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology, 1984. 34(7): p. 939-944 (Pubitemid 14076461)
10. Duda, R.O., P.E. Hart, and D.G. Stork, Pattern Classification 2001: Wiley-Interscience.
11. Koikkalainen, J., et al. Estimation of disease state using statistical information from medical imaging data. in Medical Image Computing and Computer Assisted Intervention - From statistical atlases to personnalized models workshop. 2006. Copenhagen, Denmark: MICCAI Society.
12. Lao, Z., et al., Morphological classification of brains via high-dimensional shape transformations and machine learning methods. Neuroimage, 2004. 21(1): p. 46-57. (Pubitemid 38114995)
13. Duchesne, S., et al., Predicting MCI progression to AD via automated analysis of T1 weighted MR image intensity. Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2005. 1(1 (Supplement)): p. 83.
14. Duchesne, S., et al., Successful AD and MCI differentiation from normal aging via automated analysis of MR image features. Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2005. 1(1 (Supplement)): p. 43.
15. Fan, Y., et al., Spatial patterns of brain atrophy in MCI patients, identified via high-dimensional pattern classification, predict subsequent cognitive decline. Neuroimage, 2008. 39(4): p. 1731-1743.
16. Wahlund, L.O., et al., Visual rating and volumetry of the medial temporal lobe on magnetic resonance imaging in dementia: a comparative study. J Neurol Neurosurg Psychiatry, 2000. 69(5): p. 630-635
17. Wahlund, L.O. and K. Blennow, Cerebrospinal fluid biomarkers for disease stage and intensity in cognitively impaired patients. Neurosci Lett, 2003. 339(2): p. 99-102. (Pubitemid 36254786)